References
- Stokes MB, Valeri AM, Herlitz L, et al. Light chain proximal
tubulopathy: clinical and pathologic characteristics in the modern
treatment era. J Am Soc Nephrol. 2016;27(5):1555-1565.
doi:10.1681/ASN.2015020185
- Vignon M, Javaugue V, Alexander MP, et al. Current anti-myeloma
therapies in renal manifestations of monoclonal light chain-associated
Fanconi syndrome: a retrospective series of 49 patients.Leukemia. 2017;31(1):123-129.
doi:10.1038/leu.2016.195
- Wu X, Zhang L, Feng J, et al. Bortezomib-based chemotherapy can
improve renal and tubular functions in patients with light
chain-associated Fanconi syndrome. Ann Hematol.2019;98(5):1095-1100.
doi:10.1007/s00277-018-3572-6
- Chen Z, Li J, Shi X, et al. Clinicopathological characteristics and
long-term prognosis of monoclonal immunoglobulin light chain
associated Fanconi syndrome. Ther Adv Hematol.2021;12:2040620720983127.
doi:10.1177/2040620720983127
- Liu Y, Zhu T, Xu L, Qin Y, Zhuang J. A single-center case series of
eight patients with the rare plasma cell dyscrasia of acquired Fanconi
syndrome secondary to monoclonal gammopathy. Leuk Lymphoma.2015;56(11):3124-3128.
doi:10.3109/10428194.2015.1025392
- Ma CX, Lacy MQ, Rompala JF, et al. Acquired Fanconi syndrome is an
indolent disorder in the absence of overt multiple myeloma.Blood. 2004;104(1):40-42.
doi:10.1182/blood-2003-10-3400
- Sirac C, Batuman V, Sanders PW. The proximal tubule toxicity of
immunoglobulin light chains. Kidney Int Rep.2021;6(5):1225-1231.
doi:10.1016/j.ekir.2021.02.026
- Sugimoto Y, Fujimoto M, Machida H, Nagaharu K, Murata T, Tsukada T.
Light chain proximal tubulopathy diagnosed solely by electron
microscopy of a renal biopsy specimen in a patient with monoclonal
gammopathy of undetermined significance. Int J Hematol.2021;114(3):303-304.
doi:10.1007/s12185-021-03193-9
- Feurstein S, Zoller J, Schwab C, et al. Concurrent light chain
amyloidosis and proximal tubulopathy: insights into different
aggregation behavior-A case report. EJHaem.2022;3(4):1377-1380.
doi:10.1002/jha2.555
- Chopra R, Santana de Roberts R, Batal I, Batra S, Jim B. Light chain
proximal tubulopathy with cast nephropathy in monoclonal gammopathy of
renal significance. BMJ Case Rep. 2020;13(6):e234361.
doi:10.1136/bcr-2020-234361
- Qin AB, Yu XJ, Zheng XZ, Wang SX, Zhou FD, Zhao MH. Lessons for the
clinical nephrologist: a rare case with MGRS characterized by combined
crystalline light chain proximal tubulopathy and crystal-storing
histiocytosis responding to daratumumab. J Nephrol.2023;36(4):1203-1207.
doi:10.1007/s40620-023-01584-1
- Ino A, Yamaguchi K, Taneda S, et al. Proximal tubulopathy with
fibrillary inclusions: a rare manifestation of lymphoma-associated
monoclonal gammopathy of renal significance (MGRS). Kidney Med.2019;1(6):397-401.
doi:10.1016/j.xkme.2019.07.013
- Ugai T, Tsuda K, Sugihara H, et al. Renal Fanconi syndrome associated
with monoclonal κ free light chain in a patient with Waldenström
macroglobulinemia. Br J Haematol. 2013;162(1):1.
doi:10.1111/bjh.12398
- Mathur M, Chacko B, Vankalakunti M, Patil C. Fanconi syndrome due to
light chain proximal tubulopathy in a patient with multiple myeloma.Saudi J Kidney Dis Transpl. 2016;27(4):805-807.
doi:10.4103/1319-2442.185268
- Chung EYM, McIlroy K, Fung C, Seshan SV, Moran S, Coleman PL.
Glomerular, mesangial, and tubular cytoplasmic fibrillary inclusions
in a patient with light-chain proximal tubulopathy. Nephron.2020;144(4):190-194.
doi:10.1159/000505029
- Li MN, Zhao L, Li XH, et al. Autologous peripheral blood stem cell
transplantation combined with bortezomib and dexamethasone for the
treatment of light chain proximal tubulopathy: a case report.Zhonghua Xue Ye Xue Za Zhi. 2019;40(8):703. [Article in
Chinese]
doi:10.3760/cma.j.issn.0253-2727.2019.08.019
- Li F, Xie X, Sun L, Zhang Z, Chen J, Wang X. Non-crystalline light
chain proximal tubulopathy associated with monoclonal gammopathy of
renal significance: a case report and review of the literature.Clin Nephrol. 2023;99(1):32-40.
doi:10.5414/CN110883
- Gutiérrez-Peredo GB, Filho JCBO, Montaño-Castellón I, Gutiérrez-Peredo
AJ, Crusoé EQ, Gusmao-Flores D. Lambda light chain-induced monoclonal
gammopathy of renal significance, manifesting with Fanconi syndrome
and osteomalacia. BMC Nephrol. 2022;23(1):278.
doi:10.1186/s12882-022-02901-9
- Tsuyuki T, Uramatsu T, Shimizu M, et al. Improvement of light chain
proximal tubulopathy without crystals in IgGλ-type monoclonal
gammopathy of undetermined significance using bortezomib and
dexamethasone: a case report. Intern Med. 2023.
doi:10.2169/internalmedicine.1835-23
- Kawamoto S, Hidaka Y, Kaneko Y, et al. Remission of light chain
proximal tubulopathy in IgG λ-type multiple myeloma by lenalidomide
and dexamethasone therapy. CEN Case Rep. 2019;8(3):159-165.
doi:10.1007/s13730-019-00382-8
- Ikeda D, Matsue K. Non-crystalline light chain proximal tubulopathy
without renal Fanconi syndrome in a patient with IgD-λ multiple
myeloma. Br J Haematol. 2022;196(2):261.
doi:10.1111/bjh.17785
- Kishi S, Obata F, Miki H, et al. Lambda light chain non-crystalline
proximal tubulopathy with IgD lambda myeloma. Intern Med.2018;57(24):3597-3602.
doi:10.2169/internalmedicine.1323-18
- Palladini G, Paiva B, Wechalekar A, et al. Minimal residual disease
negativity by next-generation flow cytometry is associated with
improved organ response in AL amyloidosis. Blood Cancer J.2021;11(2):34.
doi:10.1038/s41408-021-00428-0